Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.990
+0.060 (3.11%)
At close: Dec 5, 2025, 4:00 PM EST
2.000
+0.010 (0.50%)
After-hours: Dec 5, 2025, 7:10 PM EST
Estrella Immunopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -13.51 | -8.85 | -7.31 | -11.11 | -1.69 | -0.73 |
| Stock-Based Compensation | 1.34 | 0.86 | 1.19 | 0.41 | 0.13 | 0.06 |
| Change in Accounts Payable | 0.08 | 0.01 | -9.33 | 8.39 | - | - |
| Change in Income Taxes | -0.08 | -0.08 | - | - | - | - |
| Change in Other Net Operating Assets | 11.01 | 1.84 | -0.62 | 0.98 | 0.11 | - |
| Operating Cash Flow | -1.09 | -6.23 | -16.07 | -1.34 | -1.44 | -0.67 |
| Other Investing Activities | - | - | 4.96 | -0.27 | - | - |
| Investing Cash Flow | - | - | 4.96 | -0.27 | - | - |
| Short-Term Debt Issued | - | - | 0.3 | - | - | - |
| Total Debt Issued | - | - | 0.3 | - | - | - |
| Short-Term Debt Repaid | - | - | -0.3 | - | - | - |
| Total Debt Repaid | - | - | -0.3 | - | - | - |
| Issuance of Common Stock | 2.61 | 0.16 | 10 | - | 0.02 | - |
| Repurchase of Common Stock | - | -0.43 | -5.43 | - | - | - |
| Other Financing Activities | -0.05 | - | -0.8 | - | 0.52 | 0.67 |
| Financing Cash Flow | 2.55 | -0.27 | 12.79 | - | 5.53 | 0.67 |
| Net Cash Flow | 1.46 | -6.5 | 1.69 | -1.61 | 4.09 | - |
| Cash Interest Paid | - | - | 0 | - | - | - |
| Cash Income Tax Paid | 0.08 | 0.08 | 0 | - | - | - |
| Levered Free Cash Flow | - | - | -12.95 | 2.81 | - | - |
| Unlevered Free Cash Flow | - | - | -12.95 | 2.81 | - | - |
| Change in Working Capital | 11.01 | 1.76 | -9.95 | 9.37 | 0.11 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.